| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |

* From the Department of Anesthesiology and Critical Care Medicine, Kochi Medical School, Nankoku; and
the Department of Anesthesiology, The University of Tokyo, Faculty of Medicine, Tokyo, Japan.
Address correspondence to: Dr. Koichi Yamashita, Department of Anesthesiology and Critical Care Medicine, Kochi Medical School, Kohasu, Oko-cho, Nankoku-shi, Kochi, 783-8505, Japan. Phone: +81-88-880-2471; Fax: +81-88-880-2475; E-mail: koichiya{at}kochi-ms.ac.jp
| Abstract |
|---|
|
|
|---|
Methods: 23 patients who underwent OPCAB were enrolled in this study. After premedication with oral diazepam 10 mg, anesthesia was induced with midazolam, fentanyl and vecuronium. After induction, radial artery and pulmonary artery catheters were inserted. Cardiac output was measured simultaneously by the PulseCOTM and the bolus thermodilution method using the VigilanceTM monitor: 1) after sternotomy, 2) after opening the mediastinum, and 3) at the end of surgery. The PulseCOTM was calibrated initially with cardiac output determined by the thermodilution method after induction of anesthesia.
Results: The correlation coefficients between the two techniques at the three measurement periods were: 1) R2 = 0.49, 2) R2 = 0.52, 3) R2 = 0.55. The limits of agreement (bias ± 2 SD of bias) were: 1) 0.71 ± 2.66, 2) 0.30 ± 1.97, 3) 0.76 ± 3.85 L·min1.
Conclusions: Cardiac output by PulseCOTM is not interchangeable with cardiac output measured by thermodilution in patients undergoing OPCAB.
| Introduction |
|---|
|
|
|---|
| Methods |
|---|
|
|
|---|
Statistical analysis
Data are expressed as mean ± standard deviation (SD). Hemodynamic variables were analyzed by repeated measures analysis of variance with Bonferroni correction. Correlation between CO measured by the PulseCOTM and thermodilution was determined by linear regression analysis. The Blant-Altman plot was used to compare the bias (the mean of the differences) and limits of agreement (bias ± 2 SD of bias) between the two methods.6 A priori, a difference within the range of ± 0.5 L·min1 was considered clinically acceptable to support the conclusion that the two methods are interchangeable. A P-value < 0.05 was considered statistically significant.
| Results |
|---|
|
|
|---|
|
|
|
|
| Discussion |
|---|
|
|
|---|
The method to determine CO from characteristics of the arterial pressure waveform is called the pulse contour method.3 Pulse contour methods use properties of the aorta and arterial system to determine an aortic flow from an arterial pressure waveform. However, aortic pathology and variations in the aortic sectional area present challenges in calibrating arterial pressure waveform in individual patients. Therefore, pulse contour methods require calibration by another method.2 Originally a lithium chroride indicator dilution technique was used to calibrate the PulseCOTM measurement.7,8 However, in the present study, the PulseCOTM was calibrated with CO measured by the bolus thermodilution method using a pulmonary artery catheter, because a lithium chroride indicator was not available for this purpose in Japan and the bolus thermodilution method is the current standard to measure CO.1 In the present study, CO measured after induction was the same between the two methods.
The PulseCOTM has previously been reported to be a useful CO monitor after cardiac surgery.9 However, in the present study, correlation coefficients between CO measured by the PulseCOTM and thermodilution were smaller, moreover, and bias was relatively larger than documents in previous studies.2,10 The observed bias from 0.30 to 0.76 L·min1 and limits of agreement exceeding ± 0.5 L·min1 suggest that the PulseCOTM overestimates CO measured by thermodilution in patients undergoing OPCAB.
The PulseCOTM algorithm uses aortic flow velocity to calculate CO from the mean arterial pressure.2 However, velocity may change by alteration of cardiac and/or arterial compliance, even when mean arterial pressure remains the same. In cardiac surgery, cardiac compliance changes markedly due to the alteration of intrathoracic pressure by sternotomy and opening the mediastinum. In addition, arterial compliance may be altered by vasoactive drugs (e.g., phenylephrine, dopamine, nitroglycerine) or body temperature. However, the PulseCOTM cannot continuously measure the arterial compliance. Therefore, the PulseCOTM has the potential to miscalculate CO due to drift and may need several calibrations to measure CO during surgery. In our study, we calibrated the PulseCOTM only once, reflecting how it is generally used in the clinical setting.
We conclude that CO measurement by PulseCOTM is not interchangeable with CO measured by thermodilution in patients undergoing OPCAB.
| Footnotes |
|---|
| References |
|---|
|
|
|---|
2 Linton NW, Linton RA. Estimation of changes in cardiac output from the arterial blood pressure waveform in the upper limb. Br J Anaesth 2001; 86: 48696.
3 Van Lieshout JJ, Wesseling KH. Continuous cardiac output by pulse contour analysis? (Editorial). Br J Anaesth 2001; 86: 4678.
4 Jansen JR, Schreuder JJ, Mulier JP, Smith NT, Settels JJ, Wesseling KH. A comparison of cardiac output derived from the arterial pressure wave against thermodilution in cardiac surgery patients. Br J Anaesth 2001; 87: 21222.
5 Rödig G, Prasser C, Keyl C, Liebold A, Hobbhahn J. Continuous cardiac output measurement: pulse contour analysis vs thermodilution technique in cardiac surgery patients. Br J Anaesth 1999; 82: 52530.
6 Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1: 30710.[Medline]
7 Linton R, Band D, OBrien T, Jonas M, Leach R. Lithium dilution cardiac output measurement: a comparison with thermodilution. Crit Care Med 1997; 25: 1796800.[Medline]
8 Jonas MM, Tanser SJ. Lithium dilution measurement of cardiac output and arterial pulse waveform analysis: an indicator dilution calibrated beat-by-beat system for continuous estimation of cardiac output. Curr Opin Crit Care 2002; 8: 25761.[Medline]
9 Hamilton TT, Huber LM, Jessen ME. PulseCO: a less-invasive method to monitor cardiac output from arterial pressure after cardiac surgery. Ann Thorac Surg 2002; 74: S140812.
10 Segal E, Katzenelson R, Berkenstadt H, Perel A. Transpulmonary thermodilution cardiac output measurement using the axillary artery in critically ill patients. J Clin Anesth 2002; 14: 2103.[Medline]
This article has been cited by other articles:
![]() |
J. Mayer, J. Boldt, M. W. Wolf, J. Lang, and S. Suttner Cardiac Output Derived from Arterial Pressure Waveform Analysis in Patients Undergoing Cardiac Surgery: Validity of a Second Generation Device Anesth. Analg., March 1, 2008; 106(3): 867 - 872. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Button, L. Weibel, O. Reuthebuch, M. Genoni, A. Zollinger, and C. K. Hofer Clinical evaluation of the FloTrac/VigileoTM system and two established continuous cardiac output monitoring devices in patients undergoing cardiac surgery Br. J. Anaesth., September 1, 2007; 99(3): 329 - 336. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Mayer, J. Boldt, T. Schollhorn, K. D. Rohm, A. M. Mengistu, and S. Suttner Semi-invasive monitoring of cardiac output by a new device using arterial pressure waveform analysis: a comparison with intermittent pulmonary artery thermodilution in patients undergoing cardiac surgery Br. J. Anaesth., February 1, 2007; 98(2): 176 - 182. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Al-Ruzzeh Less invasive cardiac output monitoring for OPCAB surgery. Can J Anesth, October 1, 2006; 53(10): 1064 - 1065. [Full Text] [PDF] |
||||
![]() |
N. Linton Pulse contour analysis to estimate cardiac output. Can J Anesth, August 1, 2006; 53(8): 850 - 851. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |